Verona Foresees FDA End-Of-Phase II COPD Meeting

Talks Will Discuss Pivotal COPD Trials For Ensifentrine

 
• By Sten Stovall
  
Lung disease
Verona develops drugs for treating chronic respiratory diseases. • Source: Shutterstock

More from Business

More from Scrip